Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNF | P01375 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.39 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 4/20 | 0.37 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.37 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.37 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.37 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 2/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24475592 | 0.97 | TNF (0.39) | TNFNPC1RAB9APOLBCYP11B1 | |
| SCHEMBL23016133 | 0.97 | TNF (0.42) | TNFNPC1RAB9APOLBCYP11B1 | |
| SCHEMBL22282120 | 0.94 | TNF (0.40) | TNFNPC1RAB9APOLBCYP11B1 | |
| SCHEMBL23016293 | 0.94 | TNF (0.44) | TNFNPC1RAB9APOLBCYP11B1 | |
| SCHEMBL23016343 | 0.91 | IKBKE (0.43) | NPC1RAB9APOLBCYP11B1CYP11B2 | |
| SCHEMBL24475371 | 0.91 | TNF (0.41) | TNFNPC1RAB9APOLBCYP11B1 | |
| SCHEMBL23016130 | 0.91 | TNF (0.41) | TNFNPC1RAB9APOLBCYP11B1 | |
| SCHEMBL22281881 | 0.89 | TNF (0.43) | TNFNPC1RAB9ACYP11B1CYP11B2 | |
| SCHEMBL23016358 | 0.89 | NPC1 (0.43) | NPC1RAB9APOLBCYP11B1CYP11B2 | |
| SCHEMBL24475397 | 0.89 | IKBKE (0.41) | NPC1RAB9APOLBCYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10930857-B2 | Heterocyclic compound and organic light emitting device using same | LT MATERIALS CO., LTD. (KR) | 2021-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10930857-B2 | Heterocyclic compound and organic light emitting device using same | CRY1, CRY2, CYBA | TNF 1871/4885NPC1 4299/4885RAB9A 3913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.